Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 5 points (0.0%) at 15,100 as of Thursday, May 9, 2013, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,176 issues advancing vs. 1,742 declining with 136 unchanged. The Health Services industry currently sits down 0.21 versus the S&P 500, which is down 0.21. On the negative front, top decliners within the industry include Orthofix International N.V ( OFIX), down 16.31, HCA Holdings ( HCA), down 1.43, DaVita HealthCare Partners ( DVA), down 1.24 and UnitedHealth Group ( UNH), down 1.22. TheStreet Ratings group would like to highlight 5 stocks pushing the industry lower today: 5. DENTSPLY International ( XRAY) is one of the companies pushing the Health Services industry lower today. As of noon trading, DENTSPLY International is down $2.00 (-4.5%) to $42.20 on heavy volume Thus far, 1.7 million shares of DENTSPLY International exchanged hands as compared to its average daily volume of 663,700 shares. The stock has ranged in price between $40.50-$42.65 after having opened the day at $40.55 as compared to the previous trading day's close of $44.20. DENTSPLY International Inc. designs, develops, manufactures, and markets a range of consumable dental products for the professional dental market worldwide. DENTSPLY International has a market cap of $6.2 billion and is part of the health care sector. The company has a P/E ratio of 19.9, above the S&P 500 P/E ratio of 17.7. Shares are up 11.6% year to date as of the close of trading on Wednesday. TheStreet Ratings rates DENTSPLY International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full DENTSPLY International Ratings Report now. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.